Mind Medicine Inc
MNMD
Company Profile
Business description
Mind Medicine Inc is a biopharmaceutical company. The company produces to treat brain health disorders. The company discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances. The firm is having an approach towards developing the next generation of psychedelic-inspired medicines and therapies.
Contact
One World Trade Center
Suite 8500
New YorkNY10007
USAT: +1 212 220-6633
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
57
Stocks News & Analysis
video
Do you qualify as 'rich'?
Morningstar's Sim Mody speaks with Mark LaMonica about the varying definitions of rich.
stocks
Megatrend Investing 2025 and beyond: ASX players to capitalise on the clean energy transition
Find out how you can benefit from global megatrends.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,628.40 | 161.30 | -1.84% |
| CAC 40 | 7,820.26 | 129.91 | -1.63% |
| DAX 40 | 21,343.11 | 388.94 | -1.79% |
| Dow JONES (US) | 44,544.66 | 337.47 | -0.75% |
| FTSE 100 | 8,551.74 | 122.22 | -1.41% |
| HKSE | 20,217.26 | 7.85 | -0.04% |
| NASDAQ | 19,627.44 | 54.31 | -0.28% |
| Nikkei 225 | 38,520.09 | 1,052.40 | -2.66% |
| NZX 50 Index | 12,810.32 | 184.69 | -1.42% |
| S&P 500 | 6,040.53 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,379.40 | 152.90 | -1.79% |
| SSE Composite Index | 3,250.60 | 2.03 | -0.06% |